Pharmaceuticals: Major
Italian companies operating in the same pharmaceuticals: major industry
The table below has Italian companies that operate under the same industry, pharmaceuticals: major. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Eli Lilly and Company, or spot the most traded options, such as Recordati Industria Chimica e Farmaceutica S.p.A.. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 1LLYEli Lilly and Company | 590.89 B EUR | 621.1 EUR | −2.28% | 770 | 0.67 | 48.52 | 12.80 EUR | +71.29% | 0.80% | Health technology | Strong buy |
| 4LLYEli Lilly and Company | 590.89 B EUR | 620.6 EUR | −2.36% | 0 | 0.00 | 48.48 | 12.80 EUR | +71.29% | 0.80% | Health technology | Strong buy |
 1JNJJohnson & Johnson | 368.92 B EUR | 151.96 EUR | −0.80% | 20 | 0.43 | 19.15 | 7.94 EUR | +22.89% | 2.85% | Health technology | Buy |
| 4JNJJohnson & Johnson | 368.92 B EUR | 152.54 EUR | −0.44% | 0 | 0.00 | 19.22 | 7.94 EUR | +22.89% | 2.85% | Health technology | Buy |
 1ABBVAbbVie, Inc. | 322.37 B EUR | 180.8 EUR | −1.20% | 0 | 0.00 | 101.36 | 1.78 EUR | −36.09% | 3.04% | Health technology | Buy |
| 4ABBVAbbVie, Inc. | 322.37 B EUR | 180.8 EUR | −1.09% | 0 | 0.00 | 101.36 | 1.78 EUR | −36.09% | 3.04% | Health technology | Buy |
 1ROGRoche Holding Ltd Dividend Right Cert. | 234.32 B EUR | 290 EUR | −0.68% | 25 | 0.90 | 23.08 | 12.57 EUR | −8.51% | 3.54% | Health technology | Neutral |
| 1RORoche Holding Ltd | 234.32 B EUR | 294 EUR | −6.96% | 0 | — | 23.39 | 12.57 EUR | −8.51% | 3.35% | Health technology | Neutral |
 1NOVNNovartis AG | 210.82 B EUR | 110 EUR | 0.00% | 47 | 0.11 | 17.31 | 6.35 EUR | −12.24% | 3.37% | Health technology | Neutral |
 1MRKXMerck & Co., Inc. | 181.65 B EUR | 72.0 EUR | +0.14% | 240 | 0.80 | 13.08 | 5.51 EUR | +9.30% | 3.78% | Health technology | Buy |
| 4MRKXMerck & Co., Inc. | 181.65 B EUR | 72.0 EUR | +0.14% | 50 | — | 13.08 | 5.51 EUR | +9.30% | 3.78% | Health technology | Buy |
 1PFEPfizer Inc. | 121.44 B EUR | 21.005 EUR | −0.47% | 1.58 K | 0.42 | 13.15 | 1.60 EUR | — | 6.87% | Health technology | Neutral |
| 4PFEPfizer Inc. | 121.44 B EUR | 20.985 EUR | −0.64% | 0 | 0.00 | 13.14 | 1.60 EUR | — | 6.87% | Health technology | Neutral |
 1SANSanofi SA | 96.93 B EUR | 79.44 EUR | +0.34% | 8.32 K | 1.80 | 10.80 | 7.36 EUR | +119.29% | 4.93% | Health technology | Buy |
| 4SANSanofi SA | 96.93 B EUR | 79.43 EUR | −0.18% | 20 | 0.32 | 10.80 | 7.36 EUR | +119.29% | 4.93% | Health technology | Buy |
 4VRTXVertex Pharmaceuticals Incorporated | 87.19 B EUR | 338.95 EUR | −0.62% | 0 | — | 28.54 | 11.88 EUR | — | 0.00% | Health technology | Buy |
| 1VRTXVertex Pharmaceuticals Incorporated | 87.19 B EUR | 339.10 EUR | −0.63% | 6 | 2.00 | 28.55 | 11.88 EUR | — | 0.00% | Health technology | Buy |
 4BMYBristol-Myers Squibb Company | 82.38 B EUR | 39.885 EUR | −1.49% | 0 | — | 18.96 | 2.10 EUR | — | 5.22% | Health technology | Neutral |
| 1BMYBristol-Myers Squibb Company | 82.38 B EUR | 39.890 EUR | −1.52% | 0 | 0.00 | 18.96 | 2.10 EUR | — | 5.22% | Health technology | Neutral |
 1ZTSZoetis, Inc. Class A | 58.34 B EUR | 130.76 EUR | −0.46% | 0 | 0.00 | 26.50 | 4.93 EUR | +3.48% | 1.26% | Health technology | Buy |
| 4ZTSZoetis, Inc. Class A | 58.34 B EUR | 130.78 EUR | −0.29% | 8 | — | 26.51 | 4.93 EUR | +3.48% | 1.26% | Health technology | Buy |
 1REGNRegeneron Pharmaceuticals, Inc. | 52.17 B EUR | 485.9 EUR | −0.78% | 34 | 3.91 | 14.42 | 33.69 EUR | −4.43% | 0.46% | Health technology | Buy |
| 4REGNRegeneron Pharmaceuticals, Inc. | 52.17 B EUR | 486.2 EUR | −0.69% | 0 | — | 14.43 | 33.69 EUR | −4.43% | 0.46% | Health technology | Buy |
 1ALNYAlnylam Pharmaceuticals, Inc | 50.87 B EUR | 385.4 EUR | −1.00% | 0 | — | — | −2.09 EUR | −272.81% | 0.00% | Health technology | Buy |
 1MRKMerck KGaA | 47.63 B EUR | 109.30 EUR | +0.69% | 2 | 0.01 | 16.60 | 6.59 EUR | +9.02% | 2.01% | Health technology | Buy |
| 4MRKMerck KGaA | 47.63 B EUR | 109.35 EUR | +0.64% | 0 | — | 16.61 | 6.59 EUR | +9.02% | 2.01% | Health technology | Buy |
 4UCBUCB S.A. | 39.14 B EUR | 206.20 EUR | +0.88% | 0 | — | 30.09 | 6.85 EUR | +458.55% | 0.47% | Health technology | Strong buy |
 1GALDGalderma Group AG | 36.62 B EUR | 153 EUR | +2.00% | 0 | 0.00 | 103.76 | 1.47 EUR | — | 0.10% | Health technology | Buy |
 1BAYNBayer AG | 27.66 B EUR | 28.170 EUR | −0.98% | 39.33 K | 1.19 | — | −3.48 EUR | −169.98% | 0.39% | Health technology | Buy |
| 4BAYNBayer AG | 27.66 B EUR | 28.205 EUR | −1.26% | 0 | 0.00 | — | −3.48 EUR | −169.98% | 0.39% | Health technology | Buy |
 1INSMInsmed Incorporated | 26.33 B EUR | 120.0 EUR | −1.64% | 0 | — | — | −4.84 EUR | +3.94% | 0.00% | Health technology | Strong buy |
 4BIIBBiogen Inc. | 17.71 B EUR | 121.50 EUR | +2.36% | 0 | — | 13.69 | 8.87 EUR | +19.71% | 0.00% | Health technology | Buy |
| 1BIIBBiogen Inc. | 17.71 B EUR | 121.60 EUR | +2.36% | 0 | 0.00 | 13.70 | 8.87 EUR | +19.71% | 0.00% | Health technology | Buy |
 1INCYIncyte Corporation | 14.53 B EUR | 73.18 EUR | −1.03% | 0 | — | 19.60 | 3.73 EUR | +1,027.00% | 0.00% | Health technology | Buy |
| 4INCYIncyte Corporation | 14.53 B EUR | 73.18 EUR | −0.95% | 0 | 0.00 | 19.60 | 3.73 EUR | +1,027.00% | 0.00% | Health technology | Buy |
 4SRTSartorius AG | 12.13 B EUR | 158.2 EUR | +1.80% | 0 | 0.00 | 104.91 | 1.51 EUR | +33.31% | 0.46% | Health technology | Buy |
| 1SRTSartorius AG | 12.13 B EUR | 157.2 EUR | +0.51% | 0 | 0.00 | 104.25 | 1.51 EUR | +33.31% | 0.46% | Health technology | Buy |
| 4SRT3Sartorius AG Pref | 12.13 B EUR | 191.95 EUR | +1.61% | 0 | — | 127.30 | 1.51 EUR | +33.31% | 0.38% | Health technology | Buy |
 RECRecordati Industria Chimica e Farmaceutica S.p.A. | 11.15 B EUR | 54.05 EUR | −0.46% | 248.97 K | 0.93 | 27.76 | 1.95 EUR | +5.19% | 2.35% | Health technology | Buy |
 4VTRSViatris, Inc. | 10.51 B EUR | 8.904 EUR | −0.18% | 0 | 0.00 | — | −2.47 EUR | −386.91% | 4.57% | Health technology | Neutral |
| 1VTRSViatris, Inc. | 10.51 B EUR | 8.904 EUR | −0.20% | 333 | 0.99 | — | −2.47 EUR | −386.91% | 4.57% | Health technology | Neutral |
 1ORNBVOrion Oyj Class B | 9.26 B EUR | 66.05 EUR | −1.71% | 0 | 0.00 | 24.56 | 2.69 EUR | +62.54% | 2.47% | Health technology | Buy |
| 4ORNBVOrion Oyj Class B | 9.26 B EUR | 66.05 EUR | −1.71% | 0 | — | 24.56 | 2.69 EUR | +62.54% | 2.47% | Health technology | Buy |
 1EXELExelixis, Inc. | 8.75 B EUR | 31.99 EUR | −0.16% | 30 | 0.55 | 18.07 | 1.77 EUR | +62.34% | 0.00% | Health technology | Buy |
 1SOBISwedish Orphan Biovitrum AB | 8.57 B EUR | 25.08 EUR | −0.95% | 0 | 0.00 | 22.29 | 1.13 EUR | +104.97% | 0.00% | Health technology | Buy |
 1IONSIonis Pharmaceuticals, Inc. | 8.38 B EUR | 52.50 EUR | +2.42% | 115 | 1.44 | — | −1.57 EUR | +33.35% | 0.00% | Health technology | Buy |
 1MDGLMadrigal Pharmaceuticals, Inc. | 8.28 B EUR | 368.8 EUR | −0.32% | 0 | — | — | −10.91 EUR | +54.19% | 0.00% | Health technology | Strong buy |
 1GRFGrifols, S.A. Class A | 7.41 B EUR | 12.270 EUR | +3.54% | 0 | — | 28.05 | 0.44 EUR | +95.66% | 0.99% | Health technology | Buy |
| 4GRFGrifols, S.A. Class A | 7.41 B EUR | 12.285 EUR | +0.53% | 0 | — | 28.08 | 0.44 EUR | +95.66% | 0.99% | Health technology | Buy |
 1JAZZJazz Pharmaceuticals Public Limited Company | 6.74 B EUR | 110.15 EUR | −0.81% | 0 | — | — | −5.73 EUR | −209.59% | 0.00% | Health technology | Strong buy |
 1CORTCorcept Therapeutics Incorporated. | 6.27 B EUR | 58.72 EUR | −2.59% | 0 | — | 61.56 | 0.95 EUR | −9.37% | 0.00% | Health technology | Strong buy |
 1RGENRepligen Corporation | 6.02 B EUR | 104.90 EUR | +4.59% | 0 | — | — | −0.21 EUR | −240.33% | 0.00% | Health technology | Buy |
 1CYTKCytokinetics, Incorporated | 5.45 B EUR | 45.8 EUR | +6.51% | 13 | 0.54 | — | −4.35 EUR | +13.31% | 0.00% | Health technology | Strong buy |
 1TGTXTG Therapeutics, Inc. | 4.39 B EUR | 26.860 EUR | −0.07% | 0 | 0.00 | 84.56 | 0.32 EUR | −43.30% | 0.00% | Health technology | Buy |
 1AKROAkero Therapeutics, Inc. | 3.07 B EUR | 38.59 EUR | +2.91% | 0 | — | — | −3.23 EUR | −1.28% | 0.00% | Health technology | Strong buy |
 1APLSApellis Pharmaceuticals, Inc. | 3.05 B EUR | 24.355 EUR | +2.96% | 0 | 0.00 | — | −1.55 EUR | +39.49% | 0.00% | Health technology | Buy |
 1ROVILaboratorios Farmaceuticos Rovi, S.A. | 3.02 B EUR | 59.50 EUR | +1.97% | 0 | — | 22.90 | 2.60 EUR | −7.56% | 1.27% | Health technology | Buy |
 1VKTXViking Therapeutics, Inc. | 2.6 B EUR | 22.605 EUR | +1.53% | 2.13 K | 0.76 | — | −1.30 EUR | −48.88% | 0.00% | Health technology | Strong buy |
 4OGNOrganon & Co. | 2.32 B EUR | 8.664 EUR | +3.71% | 0 | — | 3.79 | 2.29 EUR | −37.01% | 5.78% | Health technology | Neutral |
| 1OGNOrganon & Co. | 2.32 B EUR | 8.670 EUR | +3.71% | 0 | 0.00 | 3.79 | 2.29 EUR | −37.01% | 5.78% | Health technology | Neutral |
 1SRPTSarepta Therapeutics, Inc. | 1.57 B EUR | 16.070 EUR | +2.23% | 35 | 0.02 | — | −0.64 EUR | −270.53% | 0.00% | Health technology | Neutral |
 4EVTEvotec SE | 1.04 B EUR | 5.865 EUR | +2.20% | 0 | — | — | −0.88 EUR | +9.05% | 0.00% | Health technology | Buy |
| 1EVTEvotec SE | 1.04 B EUR | 5.856 EUR | +1.67% | 4.8 K | 6.46 | — | −0.88 EUR | +9.05% | 0.00% | Health technology | Buy |
 PHILPhilogen SpA | 678.43 M EUR | 23.2 EUR | +0.87% | 7.17 K | 0.57 | 20.64 | 1.12 EUR | — | 0.00% | Health technology | Strong buy |
 FFFine Foods & Pharmaceuticals N.T.M. SpA | 211.67 M EUR | 8.66 EUR | +0.46% | 15.32 K | 0.59 | 17.03 | 0.51 EUR | +376.92% | 1.39% | Health technology | Strong buy |
 4IPHInnate Pharma SA Class A | 163.32 M EUR | 1.782 EUR | −3.47% | 0 | — | — | −0.61 EUR | −546.61% | 0.00% | Health technology | Strong buy |